|
116
|
315
|
4yvvA |
Crystal structure of akr1c3 complexed with glibenclamide |
|
111
|
376
|
4zqpA |
Crystal structure of the catalytic domain of the inosine monophosphate dehydrogenase from mycobacterium tuberculosis in the complex with imp and the inhibitor mad1 |
|
206
|
616
|
4ytmA |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with n-biphenyl-3-yl-2-(trifluoromethyl)benzamide |
|
108
|
374
|
4zqnA |
Crystal structure of the catalytic domain of the inosine monophosphate dehydrogenase from mycobacterium tuberculosis in the complex with imp and the inhibitor p41 |
|
115
|
318
|
4yvpA |
Crystal structure of akr1c1 complexed with glibenclamide |
|
142
|
374
|
5delA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm59 |
|
139
|
364
|
4ylwA |
Crystal structure of human dihydroorotate dehydrogenase (dhodh) with no.33 compound |
|
61
|
250
|
4ysyB |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with n-[(2,4-dichlorophenyl)methyl]-2-(trifluoromethyl)benzamide |
|
39
|
129
|
4ysyD |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with n-[(2,4-dichlorophenyl)methyl]-2-(trifluoromethyl)benzamide |
|
87
|
285
|
4zonA |
Structure of ftmox1 with fumitremorgen b complex |
|
60
|
153
|
4ysxC |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with the specific inhibitor nn23 |
|
41
|
129
|
4yt0D |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with 2-methyl-n-[3-(1-methylethoxy)phenyl]benzamide. |
|
53
|
153
|
4yt0C |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with 2-methyl-n-[3-(1-methylethoxy)phenyl]benzamide. |
|
60
|
239
|
4ytpB |
Crystal structure of porcine heart mitochondrial complex ii bound with n-[(4-tert-butylphenyl)methyl]-2-(trifluoromethyl)benzamide |
|
61
|
250
|
4ytnB |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with n-[3-(pentafluorophenoxy)phenyl]-2-(trifluoromethyl)benzamide |
|
54
|
250
|
4yt0B |
Crystal structure of mitochondrial rhodoquinol-fumarate reductase from ascaris suum with 2-methyl-n-[3-(1-methylethoxy)phenyl]benzamide. |
|
198
|
546
|
4y2rA |
Structure of soluble epoxide hydrolase in complex with 2-(piperazin-1-yl)nicotinonitrile |
|
205
|
546
|
4y2pA |
Structure of soluble epoxide hydrolase in complex with n-methyl-1-[3-(pyridin-3-yl)phenyl]methanamine |
|
117
|
315
|
4xveA |
17beta-hsd5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3h)-one |
|
221
|
729
|
4x3vA |
Crystal structure of human ribonucleotide reductase 1 bound to inhibitor |
|
40
|
157
|
4xe6X |
Staphylococcus aureus dihydrofolate reductase complexed with nadph and 6-ethyl-5-[(3r)-3-[3-methoxy-5-(pyridin-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (ucp1061) |
|
201
|
546
|
4y2vA |
Structure of soluble epoxide hydrolase in complex with (4-bromo-3-cyclopropyl-1h-pyrazol-1-yl)acetic acid |
|
192
|
546
|
4y2uA |
Structure of soluble epoxide hydrolase in complex with tert-butyl 1,2,3,4-tetrahydroquinolin-3-ylcarbamate |
|
203
|
546
|
4y2jA |
Structure of soluble epoxide hydrolase in complex with n-[(1-methyl-1h-pyrazol-3-yl)methyl]-2-phenylethanamine |
|
40
|
157
|
4xecX |
Staphylococcus aureus dihydrofolate reductase complexed with nadph and 6-ethyl-5-[(3r)-3-[3-methoxy-5-(pyridin-4-yl)phenyl]but-1-yn-1-yl]pyrimidine-2,4-diamine (ucp1061) |
|
156
|
467
|
4xrzA |
Human cytochrome p450 2d6 bace1 inhibitor 6 complex |
|
205
|
546
|
4y2tA |
Structure of soluble epoxide hydrolase in complex with 3-[4-(benzyloxy)phenyl]propan-1-ol |
|
199
|
546
|
4y2sA |
Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)phenyl]-1h-pyrazol-4-ol |
|
195
|
546
|
4y2yA |
Structure of soluble epoxide hydrolase in complex with 2-(2-fluorophenyl)-n-[(5-methyl-2-thienyl)methyl]ethanamine |
|
193
|
546
|
4y2xA |
Structure of soluble epoxide hydrolase in complex with 2-({[2-(adamantan-1-yl)ethyl]amino}methyl)phenol |
|
201
|
546
|
4y2qA |
Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)pyridin-2-yl]piperazine |
|
133
|
411
|
4xrxA |
Crystal structure of a metabolic reductase with (e)-5-((1-methyl-5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)pyridin-2(1h)-one |
|
116
|
316
|
4xvdA |
17beta-hsd5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol |
|
119
|
315
|
4wdtA |
17beta-hsd5 in complex with 2-nitro-5-(phenylsulfonyl)phenol |
|
67
|
188
|
4wf5A |
Crystal structure of e.coli dsba soaked with compound 4 |
|
197
|
477
|
4wnaA |
Structure of the nitrogenase mofe protein from azotobacter vinelandii pressurized with xenon |
|
186
|
493
|
4x4lA |
Structure of human aldh1a1 with inhibitor cm037 |
|
193
|
509
|
4x0tA |
Structure aldh7a1 inactivated by 4-diethylaminobenzaldehyde and complexed with nad+ |
|
205
|
522
|
4wnaB |
Structure of the nitrogenase mofe protein from azotobacter vinelandii pressurized with xenon |
|
171
|
509
|
4x0uA |
Structure aldh7a1 inactivated by 4-diethylaminobenzaldehyde |
|
155
|
467
|
4wntA |
Human cytochrome p450 2d6 ajmalicine complex |
|
156
|
467
|
4wnuA |
Human cytochrome p450 2d6 quinidine complex |
|
186
|
494
|
4wp7A |
Structure of human aldh1a1 with inhibitor cm026 |
|
159
|
467
|
4wnvA |
Human cytochrome p450 2d6 quinine complex |
|
116
|
316
|
4wrhA |
Akr1c3 complexed with breakdown product of n-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4h-1,2,4-triazol-4-yl)amino)methyl)-6-methoxyphenoxy)acetamide |
|
187
|
494
|
4wpnA |
Structure of human aldh1a1 with inhibitor cm053 |
|
110
|
301
|
4wdwA |
17beta-hsd5 in complex with 3,6-dihydropyridin-1(2h)-yl(5-methyl-1h-indol-2-yl)methanone |
|
67
|
188
|
4weyA |
Crystal structure of e.coli dsba in complex with compound 17 |
|
63
|
187
|
4wetA |
Crystal structure of e.coli dsba in complex with compound 16 |
|
109
|
306
|
4wdxA |
17beta-hsd5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1h-indol-2-yl)methanone |
